Bupropion for Weight Loss: How It Compares to GLP-1 Medications

Bupropion shows up in weight loss conversations more often than people expect, partly because it’s been around for decades and partly because it does produce modest weight loss in some patients. If you’re trying to understand how it fits into the current landscape of weight loss medications, and how it stacks up against GLP-1 options like semaglutide and tirzepatide, here’s a clear-eyed look at what the evidence actually shows.

What Bupropion Is and How It Works

Bupropion is primarily an antidepressant and smoking cessation medication. It works by inhibiting the reuptake of dopamine and norepinephrine in the brain, which affects mood, motivation, and to some degree appetite. Weight loss is a known side effect for some patients taking bupropion, which led to its investigation as a weight management tool.

It’s available as a standalone medication under brand names like Wellbutrin, and it’s also combined with naltrexone in a fixed-dose formulation called Contrave, which is FDA-approved specifically for chronic weight management. The naltrexone component works on opioid receptors involved in reward pathways, and the combination is thought to reduce food cravings more effectively than either drug alone.

As a weight loss mechanism, bupropion’s effect is modest and variable. Not every patient experiences weight loss on it, and for those who do, the results tend to be smaller than what GLP-1 medications produce in clinical trials.

What the Research Shows on Weight Loss

Clinical trials of bupropion-naltrexone (Contrave) have shown average weight loss of around 5 percent of body weight over one year in patients who also follow a reduced-calorie diet and exercise program. That’s a meaningful result for patients with moderate weight loss goals, but it’s substantially less than what GLP-1 medications typically produce.

For comparison, semaglutide at the 2.4mg weekly dose used in the STEP trials produced average weight loss of approximately 15 percent of body weight over 68 weeks. Tirzepatide in the SURMOUNT trials showed even greater results, with some dose groups averaging over 20 percent body weight reduction. The gap between bupropion-based medications and GLP-1 medications in terms of absolute weight loss is significant.

A key study worth noting here is the STEP 1 trial, published in the New England Journal of Medicine, which demonstrated that once-weekly semaglutide 2.4mg produced 14.9 percent mean weight loss versus 2.4 percent with placebo in adults with obesity or overweight with at least one weight-related condition. No comparable bupropion trial has come close to those numbers.

Side Effect Profiles

Both medication classes carry side effect risks, but the profiles look different.

Bupropion’s most notable risks include increased blood pressure, insomnia, dry mouth, and a dose-dependent increase in seizure risk, which is why it’s contraindicated in patients with a history of seizure disorders or eating disorders involving purging. It also carries a black box warning for increased suicidal thoughts in young adults, consistent with other antidepressants.

GLP-1 medications like semaglutide and tirzepatide most commonly cause gastrointestinal side effects, particularly nausea, vomiting, and constipation, especially during dose escalation. These tend to improve as the body adjusts. Serious risks are less common but include pancreatitis and, based on animal studies, a theoretical risk of thyroid C-cell tumors, which is why GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma.

For patients who are sensitive to psychiatric medication side effects or who have a history of conditions that make bupropion inappropriate, GLP-1 medications may be the more suitable option. For patients who are already on bupropion for depression and experiencing weight loss as a side effect, that’s a different conversation worth having with their provider. The article on Ozempic and Wellbutrin covers what patients should know about taking both medications together.

Who Bupropion Might Still Make Sense For

Bupropion isn’t without a legitimate role in weight management. For patients who have depression or are trying to quit smoking and also want to avoid weight gain (a common concern with some antidepressants and during smoking cessation), bupropion addresses multiple needs at once. For patients who are not candidates for GLP-1 therapy or who have tried it without success, bupropion-naltrexone is an FDA-approved alternative with a reasonable evidence base.

It’s also substantially less expensive than GLP-1 medications, which matters for patients who can’t access compounded options or don’t qualify for manufacturer savings programs.

How GLP-1 Medications Compare

The honest comparison is this: GLP-1 medications produce significantly greater average weight loss than bupropion-based options, they work through a different and more direct mechanism of appetite suppression, and they have additional metabolic benefits including improvements in blood sugar, blood pressure, and cardiovascular risk that bupropion doesn’t offer.

For patients with a BMI that qualifies them for GLP-1 therapy and no contraindications, the clinical evidence strongly favors GLP-1 medications as the more effective intervention. The question of which specific GLP-1 medication to start with, and whether compounded or brand-name is the right fit, is worth discussing with a provider who specializes in this area.

Consider this scenario: a patient is taking bupropion for depression and has lost a few pounds as a side effect, but their weight loss goals are more significant than what bupropion alone can deliver. Adding a GLP-1 medication to their regimen, under provider supervision, may be the more effective path forward. That kind of combination requires careful clinical oversight, but it’s a conversation worth having.

TrimRx provides access to compounded semaglutide starting around $179 per month, as well as compounded tirzepatide and brand-name GLP-1 options, all through a telehealth model that doesn’t require an in-person visit. If you’re weighing your medication options and want a provider who specializes in GLP-1 weight loss, start your assessment to find out if you’re a candidate.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.